Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
Identifying mutation-derived neoantigens by proteogenomics requires robust strategies for quality control. Here, the authors propose peptide retention time as an evaluation metric for proteogenomics quality control methods, and develop a deep learning algorithm for accurate retention time prediction...
Main Authors: | Bo Wen, Kai Li, Yun Zhang, Bing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15456-w |
Similar Items
-
ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection
by: Yuyu Li, et al.
Published: (2020-04-01) -
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data
by: Chi Zhou, et al.
Published: (2019-10-01) -
Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
by: Peng Bai, et al.
Published: (2021-01-01) -
Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM proteogenomics sub-challenge
by: Tara Eicher, et al.
Published: (2019-12-01) -
Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)